2024 Precision Health Summit: Leading the Future of Personalized Medicine and AI-Driven Healthcare

Industry Pioneers Gather at One World Trade Center to Explore How Precision Health is Transforming Patient Care Through Innovation, Genomics, and Artificial Intelligence

The 2024 Precision Health Summit, one of the world’s most comprehensive events dedicated to precision health and personalized medicine, will take place at One World Trade Center in New York City from October 9-10, 2024, with a virtual attendance option. As the global healthcare landscape shifts toward more individualized care, this summit brings together industry pioneers to explore how artificial intelligence (AI), big data, and genomics are transforming medicine and revolutionizing patient care.

Precision health marks a fundamental shift in healthcare, moving away from one-size-fits-all treatments to highly personalized solutions tailored to an individual's genetic makeup, lifestyle, and environment. This model allows for more precise interventions, from earlier diagnostics to targeted therapies, resulting in improved outcomes and reduced costs across healthcare systems. As these technologies evolve, they are not only extending lifespans but also enhancing healthspans, empowering individuals to live healthier lives for longer periods.

The 2024 Precision Health Summit will cover key areas such as personalized nutrition, maternal health, preventive medicine, and longevity, with an emphasis on how precision medicine can bridge the gap between scientific innovation and patient-centric care. The event will provide insights into how AI-driven diagnostics, data analytics, and genomics are reshaping the future of healthcare, enabling more tailored and effective treatments.

A stellar lineup of speakers from across the healthcare, life sciences, and technology sectors will share their expertise, including:

- Ali Mostashari – Founder & CEO, LifeNome

- Peter Marks – Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

- Joshua Di Frances – Head of Incubation & Venture Building, LG Electronics

- Willie Reaves – Head of Public Engagement, Cellino

- Raya Khanin – Chief Scientist, LifeNome

- Poroshat Shekarloo – Director of Global Health, Maimonides Medical Center

- Arda Ural – Americas Life Sciences Leader, EY

- Alfredo Carvajal – CEO, Alma Health

- Andy Moose – Head of Health and Wellness, World Economic Forum

- Martin Alexander Gershon – Principal, Endeavor Venture Fund and Venture Studio

- Asieh Golozar – VP, Global Head of Data Science, Odysseus Data Services

- Nicole Avena – Associate Professor of Neuroscience, Mount Sinai Icahn School of Medicine

- Parastoo Khoshakhlagh – Co-Founder & CEO, GC Therapeutics

- Bill Weeks – Director, AI for Health, Microsoft

- Brigitte Arduini – Principal Investigator, Neural Stem Cell Institute

- Alan Gobbs – Co-Founder & Managing Partner, ATEM Capital

- Mario Storga – VP of Technology, LifeNome

- Lee-Anne Zinetti – Executive Director, Healthcare Systems & Diagnostics, Novartis

- Gabriele Allegri – VP, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine

- Matthias Wagner – Co-Founder & CTO, Cellino

- Aquil Harjivan – R&D Head Front-End Innovation, Bayer

- Fern Lazar – Managing Partner, Global Health Practice Leader, FINN Partners

- Christina Kotsi – Director, Medical Digital Lead Global Medical Affairs, Oncology, Bayer

- Sarah Pesce – COO, Thorne Lab

- Pooja Majmudar – Venture Partner, Keles

AI and personalized medicine are expected to address some of the most pressing challenges in modern healthcare, from chronic diseases to the need for more equitable care solutions. By leveraging AI-driven platforms, healthcare systems can now analyze vast datasets in real-time, helping doctors make more informed decisions tailored to individual patients. These advances are particularly crucial for addressing complex diseases like cancer, cardiovascular conditions, and autoimmune disorders.

The summit will be structured around Business, Science andTechnology tracks, and with sessions focusing on the commercialization of precision medicine innovations, regulatory frameworks, and the practical implementation of these technologies in clinical settings. The discussions will also examine the intersection of regenerative medicine, data science, and genomics, offering participants a comprehensive view of how precision medicine is rapidly evolving.

This landmark event will provide a platform for dialogue between healthcare leaders, innovators, and regulators, fostering the collaboration needed to drive the field forward. It is a great initiative to gain invaluable insights into the latest trends and developments, explore strategies for scaling precision health solutions, and discover how leading organizations are positioning themselves at the forefront of this healthcare revolution.

>>> FOR MORE INFORMATION ON THE SPEAKERS, THE PROGRAM, AND THE SUMMIT, PLEASE VISIT THE SUMMIT SITE:

https://1businessworld.com/precision-health-summit/

Ali Mostashari, Ph.D Peter Marks Joshua Di Frances Willie T. Reaves Jr. Raya Khanin Poroshat Shekarloo MD Arda Ural, MSc, MBA, PhD Alfredo Carvajal Andy Moose Dr. D. Martin Alexander Gershon, MD, JD, MPH Asieh Golozar Dr. Nicole Avena Parastoo Khoshakhlagh, Ph.D. William Brinson Weeks, MD, PhD, MBA Brigitte Arduini Allan Gobbs Mario Storga Lee-Anne Zinetti Gabriele Allegri Matthias Wagner Aquil Harjivan Fern Lazar Christina Kotsi Sarah Pesce Pooja M.